NervGen Pharma Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2017
Period Ending	Dec '24 Dec 20, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2017
Market Capitalization	211	161	94	124	78	58	Upgrade
Market Cap Growth	57.88%	71.42%	-24.19%	58.14%	36.12%	-	Upgrade
Enterprise Value	190	146	66	116	71	51	Upgrade
Last Close Price	3.00	2.70	1.60	2.73	2.23	1.96	Upgrade
PB Ratio	22.94	-80.10	6.97	7.36	13.23	9.85	Upgrade
P/TBV Ratio	20.73	-	7.21	7.58	14.37	10.79	Upgrade
Debt / Equity Ratio	0.01	-0.10	0.02	-	-	-	Upgrade
Quick Ratio	1.59	0.79	2.20	15.76	7.50	4.58	Upgrade
Current Ratio	1.66	0.83	2.27	16.16	8.21	6.77	Upgrade
Return on Equity (ROE)	-336.09%	-390.89%	-136.87%	-111.94%	-190.21%	-233.74%	Upgrade
Return on Assets (ROA)	-74.07%	-59.88%	-68.90%	-65.17%	-104.12%	-125.02%	Upgrade
Return on Capital (ROIC)	-196.47%	-186.22%	-94.17%	-70.43%	-118.99%	-147.57%	Upgrade
Earnings Yield	-12.36%	-13.91%	-22.07%	-10.28%	-14.28%	-16.98%	Upgrade
FCF Yield	-9.02%	-7.02%	-18.96%	-6.68%	-8.05%	-14.07%	Upgrade
Buyback Yield / Dilution	-9.52%	-12.61%	-34.00%	-22.35%	-23.97%	-221.14%	Upgrade
Total Shareholder Return	-9.52%	-12.61%	-34.00%	-22.35%	-23.97%	-221.14%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.